These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 30014596)

  • 21. Q-Switched Neodymium-Doped Yttrium Aluminum Garnet laser therapy for pigmented skin lesions: efficacy and safety.
    Karn D; K C S; Amatya A; Razouria EA; Timalsina M; Suwal A
    Kathmandu Univ Med J (KUMJ); 2012; 10(38):46-50. PubMed ID: 23132475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet laser for melasma with pre- or post-treatment triple combination cream.
    Jeong SY; Shin JB; Yeo UC; Kim WS; Kim IH
    Dermatol Surg; 2010 Jun; 36(6):909-18. PubMed ID: 20384749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Commentary on The Clinical and Histological Effect of a Low-Fluence Q-Switched 1,064-nm Neodymium: Yttrium-Aluminum-Garnet Laser for the Treatment of Melasma and Solar Lentigenes in Asians.
    Kauvar ANB
    Dermatol Surg; 2017 Sep; 43(9):1134-1136. PubMed ID: 28661993
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term results in low-fluence 1064-nm Q-Switched Nd:YAG laser for melasma: Is it effective?
    Gokalp H; Akkaya AD; Oram Y
    J Cosmet Dermatol; 2016 Dec; 15(4):420-426. PubMed ID: 27349828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Punctate leucoderma after low-fluence 1,064-nm quality-switched neodymium-doped yttrium aluminum garnet laser therapy successfully managed using a 308-nm excimer laser.
    Kim HS; Jung HD; Kim HO; Lee JY; Park YM
    Dermatol Surg; 2012 May; 38(5):821-3. PubMed ID: 22540921
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of melasma with low fluence, large spot size, 1064-nm Q-switched neodymium-doped yttrium aluminum garnet (Nd:YAG) laser for the treatment of melasma in Fitzpatrick skin types II-IV.
    Brown AS; Hussain M; Goldberg DJ
    J Cosmet Laser Ther; 2011 Dec; 13(6):280-2. PubMed ID: 21992660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of 1064-nm Q-switched neodymium-doped yttrium-aluminum-garnet laser with Modified Jessner's peel for the treatment of Nevus of Ota: A case series of seven patients.
    Raj C; Dixit N; Debata I; Hassanandani T; Behera D; Panda M
    Dermatol Ther; 2020 Nov; 33(6):e14384. PubMed ID: 33089642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improvement of hyperpigmentation within a plexiform neurofibroma after treatment with Q-switched neodymium:yttrium-aluminium-garnet laser.
    Fremlin GA; Szczecinska W; Maheshwari M; Abdullah A
    Clin Exp Dermatol; 2016 Apr; 41(3):336-7. PubMed ID: 26880255
    [No Abstract]   [Full Text] [Related]  

  • 29. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
    Ustuner P; Balevi A; Ozdemir M
    J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical efficacy of the dual-pulsed Q-switched neodymium:yttrium-aluminum-garnet laser: Comparison with conservative mode.
    Kim BW; Lee MH; Chang SE; Yun WJ; Won CH; Lee MW; Choi JH; Moon KC
    J Cosmet Laser Ther; 2013 Dec; 15(6):340-1. PubMed ID: 23789827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of topical application of 1% tetracaine gel before and after the procedure in removal of cutaneous pigmentation with Q-switched neodymium-doped yttrium aluminium garnet laser (1064/532 nm).
    Luo DQ; Yang W
    Photomed Laser Surg; 2010 Apr; 28(2):213-7. PubMed ID: 19715432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dermoscopy as a useful tool for evaluating melasma and assessing the response to 1064-nm Q-switched Nd:YAG laser.
    Abdel Hay R; Mohammed FN; Sayed KS; Abd El Fattah NA; Ibrahim S
    Dermatol Ther; 2020 Jul; 33(4):e13629. PubMed ID: 32431000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is Q-switched neodymium-doped yttrium aluminium garnet laser an effective approach to treat xanthelasma palpebrarum? Results from a clinical study of 76 cases.
    Karsai S; Schmitt L; Raulin C
    Dermatol Surg; 2009 Dec; 35(12):1962-9. PubMed ID: 19708874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melanogenesis inhibition in mice using a low-fluence 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser: a pilot study.
    Nam JH; Min JH; Kim WK; Yim S; Kim WS
    Lasers Med Sci; 2017 Jul; 32(5):1063-1069. PubMed ID: 28429191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of café-au-lait macules with a high-fluenced 1064-nm Q-switched neodymium:yttrium aluminum garnet laser.
    Kim J; Hur H; Kim YR; Cho SB
    J Cosmet Laser Ther; 2018 Feb; 20(1):17-20. PubMed ID: 28682146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination of CO2 and Q-switched Nd:YAG lasers is more effective than Q-switched Nd:YAG laser alone for eyebrow tattoo removal.
    Radmanesh M; Rafiei Z
    J Cosmet Laser Ther; 2015 Apr; 17(2):65-8. PubMed ID: 25411720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: A prospective split-face study.
    Guo X; Cai X; Jin Y; Zhang T; Wang B; Li Q
    Oncol Lett; 2019 Oct; 18(4):4136-4143. PubMed ID: 31516612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of xanthelasma palpebrarum with a 1064-nm, Q-switched Nd:YAG laser.
    Heng JK; Chua SH; Goh CL; Cheng S; Tan V; Tan WP
    J Am Acad Dermatol; 2017 Oct; 77(4):728-734. PubMed ID: 28666611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of melasma treatment focusing on laser and light devices.
    Li JY; Geddes ER; Robinson DM; Friedman PM
    Semin Cutan Med Surg; 2016 Dec; 35(4):223-232. PubMed ID: 27918005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The efficacy of energy-based devices combination therapy for melasma.
    Iranmanesh B; Khalili M; Mohammadi S; Amiri R; Aflatoonian M
    Dermatol Ther; 2021 May; 34(3):e14927. PubMed ID: 33665885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.